Sterling
Eli Lilly logo
Eli Lilly
Novo Nordisk logo
Novo Nordisk

Revenue Comparison

Chart: Revenue Comparison. Values in USD billions. In Q2 2026: Eli Lilly 22.974, Novo Nordisk 12.087.

Eli Lilly vs Novo Nordisk Net Worth and Market Cap

Eli Lilly (LLY) and Novo Nordisk (NVO) are peers in GLP-1. Eli Lilly reported revenue of $23.0B as of Q2 2026, compared with $12.1B for Novo Nordisk. Eli Lilly leads on revenue.

Eli Lilly's gross margin is 85.8% versus 78.2% for Novo Nordisk. Eli Lilly's net margin is 30.9% versus 26.7% for Novo Nordisk.

Key differences

  • Revenue growth from Q2 2025 to Q2 2026: Eli Lilly +47.7%, Novo Nordisk +2.1%.
  • Eli Lilly keeps more of its revenue as operating profit: a 54.2% operating margin, against 34.5% at Novo Nordisk.
  • Eli Lilly's KPIs on Sterling include Cardiometabolic Manufacturing Capex Announcements by Site (Cumulative) and Foundayo Quarterly Revenue.
  • Novo Nordisk's KPIs on Sterling include Next-Generation Obesity: CagriSema + Amycretin Readouts and 2030 Ambitions (Capital Markets Day, 21 Sep 2026).

Latest Quarter Comparison

Table: Latest Quarter Comparison. 15 rows across Metric, Eli Lilly, Novo Nordisk.
MetricEli LillyNovo Nordisk
Market Cap--
Revenue$22.97B$12.09B
Cost of Revenue$3.27B$2.63B
Gross Profit$19.71B$9.45B
Operating Income$12.46B$4.17B
Net Income$7.09B$3.23B
R&D Expense$3.82B$2.74B
Earnings Per Share$7.94$0.73
Gross Margin85.8%78.2%
Operating Margin54.2%34.5%
Net Profit Margin30.9%26.7%
Free Cash Flow$7.76B$6.53B
Cumulative Free Cash Flow$109.66B$107.39B
Operating Cash Flow$10.69B$8.50B
Cash & Equivalents$8.89B$6.85B

Ask Sterling

Register for a premium account to gain access to Sterling AI.

Get Started

Things you can ask Sterling:

Summarize Tesla's latest earnings reportWhy did NVIDIA's margins expand?Compare Apple vs Microsoft's cash flowWhat's driving EV industry growth?
Menu
Favorites